Article Information
History
- February 3, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Célia Sentis1,2,
- Geneviève Billaud1,
- Antonin Bal1,2,3,
- Emilie Frobert1,2,
- Maude Bouscambert1,
- Gregory Destras1,2,3,
- Laurence Josset1,2,3,
- Bruno Lina1,2,
- Florence Morfin1,2,
- Alexandre Gaymard1,2,*,
- the COVID-Diagnosis HCL Study Group
- 1Laboratoire de Virologie, Institut des Agents Infectieux, Laboratoire associé au Centre National de Référence des virus des infections respiratoires, Hospices Civils de Lyon, Lyon, France
- 2CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France
- 3GenEPII platform, Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon France
- ↵*Corresponding author:
Alexandre Gaymard, Pharm.D, Ph.D, Praticien hospitalo-universitaire (PHU), Laboratoire de Virologie (Pr B. Lina), Institut des Agents Infectieux, Hospices Civils de Lyon, Phone: +33 (0)4 72 07 10 53, Email: alexandre.gaymard{at}chu-lyon.fr
Posted February 03, 2022.
SARS-CoV-2 Omicron variant, lineage BA.1, is associated with lower viral load in nasopharyngeal samples compared to Delta variant
